Croda International (LON:CRDA) Issues Earnings Results

Croda International (LON:CRDAGet Free Report) posted its quarterly earnings data on Tuesday. The company reported GBX 146.20 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Croda International had a return on equity of 6.96% and a net margin of 9.98%.

Here are the key takeaways from Croda International’s conference call:

  • FY2025 underlying results showed improvement with sales +7% (cc) to £1.7bn, adjusted operating profit +8% to £295m, adjusted PBT +8% to £276m, free cash flow £162m and net debt reduced to £524m (1.3x EBITDA).
  • The company is executing a transformation program targeting £100m of annualized savings and £50m working capital reduction by 2028, and is guiding to >20% adjusted operating margin, >12% free cash flow-to-sales and >10% ROIC by 2028.
  • Reported profit before tax was materially below adjusted PBT—£91m vs £276m—after £150m of exceptional charges
  • Portfolio and demand trends underpin growth: sales of patented ingredients rose 9%, Flavours & Fragrances grew ~15%, Crop Protection +14%, and the business mix now has 89% exposure to Consumer/Pharma/Agriculture and 48% of sales outside Europe/North America.
  • Near-term guidance: management expects organic group growth of ~3–6% (with Consumer 3–6% and Life Sciences 4–7%), Q1 sales broadly flat vs a strong Q1-2025, and adjusted operating profit in line with market expectations.

Croda International Price Performance

CRDA opened at GBX 3,151 on Tuesday. The business has a fifty day moving average of GBX 2,811.57 and a 200 day moving average of GBX 2,733.97. The stock has a market cap of £4.40 billion, a P/E ratio of 20.46, a PEG ratio of 1.40 and a beta of 0.74. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. Croda International has a 52-week low of GBX 2,426.77 and a 52-week high of GBX 3,372.60.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group lowered Croda International to a “hold” rating and decreased their price target for the company from GBX 3,100 to GBX 3,000 in a report on Tuesday, November 11th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Croda International has an average rating of “Hold” and an average target price of GBX 3,112.50.

View Our Latest Report on CRDA

Croda International Company Profile

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

Recommended Stories

Earnings History for Croda International (LON:CRDA)

Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.